TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9631752

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) administered every 4 weeks, with NSAIDs initially maintained.
Number of subjects: 7
Study: 7868668

Group type: EXPERIMENTAL
Intervention: Tru-Trax system using bovine mucus
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Tru-Trax system using human mucus
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Post-coital tests using human mucus in the Tru-Trax system
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Overall penetration into either human or bovine mucus
Number of subjects: 133
Study: 2969002

Group type: EXPERIMENTAL
Intervention: Daily prednisone (100 micrograms/kg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Alternate day prednisone (200 micrograms/kg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Daily and alternate day prednisone treatments
Number of subjects: 8
Study: 30443729

Group type: EXPERIMENTAL
Intervention: Low-normal MAP (65-75 mmHg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: High-normal MAP (80-100 mmHg)
Number of subjects: 120
Study: 28915067

Group type: EXPERIMENTAL
Intervention: Gain-framed messages
Number of subjects: 211

Group type: COMPARATOR
Intervention: Loss-framed messages
Number of subjects: 211
Study: 25740262

Group type: COMPARATOR
Intervention: Daclatasvir (DCV) single oral doses of 1/10/50/100/200 mg
Number of subjects: 129

Group type: COMPARATOR
Intervention: Asunaprevir (ASV) single oral doses of 200/400/600/900/1200 mg
Number of subjects: 129

Group type: COMPARATOR
Intervention: Daclatasvir (DCV) multiple oral doses of 1/10/100 mg once-daily for 14 days
Number of subjects: 129

Group type: COMPARATOR
Intervention: Asunaprevir (ASV) multiple oral doses of 200/400/600 mg every 12 hours for 14 days
Number of subjects: 129
Study: 23739921

Group type: EXPERIMENTAL
Intervention: Isotonic hand exercises
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Isometric hand exercises
Number of subjects: 52
Study: 20625270

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 97
Study: 18280668

Group type: EXPERIMENTAL
Intervention: Computer-assisted, counselor-delivered smoking cessation program
Number of subjects: 426

Group type: COMPARATOR
Intervention: Standard care condition
Number of subjects: 426
Study: 16504492

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg once daily for 5 days
Number of subjects: 563

Group type: COMPARATOR
Intervention: Levofloxacin 500 mg once daily for 7 days
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 563

Group type: COMPARATOR
Intervention: Levofloxacin
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: Moxifloxacin and Levofloxacin
Number of subjects: 563
Study: 12589011

Group type: EXPERIMENTAL
Intervention: Head-up tilt test (HUTT) with haemodynamic instability score (HIS)
Number of subjects: 40
Study: 10857822

Group type: EXPERIMENTAL
Intervention: Erbium laser phacoemulsification
Number of subjects: 34
Study: 8871412

Group type: EXPERIMENTAL
Intervention: Hyperactivating AAI strategies
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Deactivating AAI strategies
Number of subjects: 61
Study: 1641600

Group type: EXPERIMENTAL
Intervention: roxithromycin 150 mg b.i.d.
Number of subjects: 86

Group type: COMPARATOR
Intervention: erythromycin stearate 500 mg b.i.d.
Number of subjects: 86
Study: 6672890

Group type: EXPERIMENTAL
Intervention: Face-mask during sleep
Number of subjects: 20

Group type: COMPARATOR
Intervention: No face-mask during sleep
Number of subjects: 20
Study: 28138753

Group type: EXPERIMENTAL
Intervention: Compliance with CONSORT criteria
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Correct implementation of CONSORT criteria
Number of subjects: 6
Study: 27776536

Group type: EXPERIMENTAL
Intervention: Low glycaemic index breakfast (dark chocolate, walnuts, yogurt, and an apple; glycaemic index of 29.4; energy contribution of 1489 kJ)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: High glycaemic index breakfast (bread, grape juice, and strawberry jam; glycaemic index of 64.0; energy contribution of 1318 kJ)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control condition (water)
Number of subjects: 3
Study: 23525574

Group type: EXPERIMENTAL
Intervention: Adalimumab plus ciprofloxacin
Number of subjects: 76

Group type: COMPARATOR
Intervention: Adalimumab plus placebo
Number of subjects: 76
Study: 23678504

Group type: EXPERIMENTAL
Intervention: Brief interventions (BIs) performed by occupational doctors, 10-minute average duration, motivational approach
Number of subjects: 787

Group type: COMPARATOR
Intervention: Control group received information booklets from doctors' assistants
Number of subjects: 787
Study: 20710083

Group type: EXPERIMENTAL
Intervention: Cervical manipulation (specific dosage and duration not provided)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standardization of adverse event terminology and reporting
Number of subjects: 0
Study: 17981886

Group type: EXPERIMENTAL
Intervention: Histopathological scoring by nephropathologists
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Activity index for LN
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Chronicity index for LN
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: WHO1995 and ISN/RPS2003 classification systems for LN
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Patients classified as IV-S
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Comparison between IV-S and IV-G
Number of subjects: 87
Study: 17130263

Group type: EXPERIMENTAL
Intervention: Olmesartan (40 mg) for 16 weeks
Number of subjects: 52

Group type: COMPARATOR
Intervention: Healthy control individuals (25 subjects)
Number of subjects: 52
Study: 15200727

Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study: 11552355

Group type: EXPERIMENTAL
Intervention: McKenzie-concept, mobilisation therapies, traction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active physiotherapies (training of local strength endurance of back and abdominal muscles)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pain reducing physical therapies (cold or electrotherapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-steroidal anti-inflammatory drugs, analgesics, muscle relaxants
Number of subjects: 0
Study: 9382981

Group type: EXPERIMENTAL
Intervention: Interferon‐α therapy
Number of subjects: 37
Study: 8037993

Group type: EXPERIMENTAL
Intervention: Nitrates (40 mg isosorbide dinitrate twice daily)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 2967448

Group type: EXPERIMENTAL
Intervention: Fenoterol 200 micrograms + Ipratropium 80 micrograms
Number of subjects: 10

Group type: COMPARATOR
Intervention: Salbutamol 200 micrograms
Number of subjects: 10
Study: 31281988

Group type: EXPERIMENTAL
Intervention: ONO-4474 (100 mg, orally, twice daily for 28 days)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: ONO-4474
Number of subjects: 110

Group type: COMPARATOR
Intervention: ONO-4474 vs Placebo
Number of subjects: 110
Study: 29165623

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 546

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 546

Group type: EXPERIMENTAL
Intervention: Venlafaxine XR 75-mg/day
Number of subjects: 546

Group type: EXPERIMENTAL
Intervention: Escitalopram 10-20 mg/day
Number of subjects: 546

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 546

Group type: EXPERIMENTAL
Intervention: Oral 17-beta-estradiol 0.5-mg/day
Number of subjects: 546

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids 1.8 g/day
Number of subjects: 546
Study: 27393470

Group type: EXPERIMENTAL
Intervention: Small-extent group (SEG) - ILM peeled with a radius of 0.75 disc diameter
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Large-extent group (LEG) - ILM peeled with a radius of 1.5 disc diameter
Number of subjects: 65
Study: 24693945

Group type: EXPERIMENTAL
Intervention: Whole body vibration exercise twice a week for 3 months
Number of subjects: 120

Group type: COMPARATOR
Intervention: General exercise twice a week for 3 months
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Whole body vibration exercise
Number of subjects: 120

Group type: COMPARATOR
Intervention: General exercise
Number of subjects: 120
Study: 24366025

Group type: EXPERIMENTAL
Intervention: Health Belief Model (HBM)-based intervention
Number of subjects: 90

Group type: COMPARATOR
Intervention: Traditional knowledge-based intervention
Number of subjects: 90
Study: 20632193

Group type: EXPERIMENTAL
Intervention: lafutidine (20 mg/day)
Number of subjects: 447

Group type: COMPARATOR
Intervention: famotidine (40 mg/day)
Number of subjects: 447

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 447
Study: 17554249

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (20 mg/day elemental zinc in multivitamin syrup for 2 weeks)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Multivitamin syrup without zinc (control)
Number of subjects: 56
Study: 16640099

Group type: EXPERIMENTAL
Intervention: d4T (stavudine)
Number of subjects: 600

Group type: COMPARATOR
Intervention: tenofovir DF
Number of subjects: 600
Study: 12792126

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group therapy (CBGT)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 47
Study: 10431556

Group type: EXPERIMENTAL
Intervention: Brief education
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Combined education
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Additional group education
Number of subjects: 564
Study: 8551210

Group type: EXPERIMENTAL
Intervention: Tabular memory network retrieval strategy (PRODUCT)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Nontabular memory network retrieval strategy (ERROR RATE)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Computational strategy (MIN)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Addition Efficiency
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Speediness of information processing
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Digit-span measure of Short-Term Memory
Number of subjects: 266
Study: 2276389

Group type: EXPERIMENTAL
Intervention: omeprazole 20 mg once daily
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: cimetidine 400 mg b.d.
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 474478

Group type: EXPERIMENTAL
Intervention: High fiber diet
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low fiber diet
Number of subjects: 12
Study: 30297735

Group type: EXPERIMENTAL
Intervention: Bilateral median nerve stimulation at low or high frequencies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unilateral median nerve stimulation at interelectrode distances of 2 and 4 cm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Electrical stimulation of the thumb on the palm side
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Activation of C-fibers with capsaicin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Median nerve stimulation
Number of subjects: 0
Study: 26475246

Group type: EXPERIMENTAL
Intervention: Intravenous fluid bolus administration guided by noninvasive cardiac output monitor after passive leg-raising maneuver
Number of subjects: 122

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 122
Study: 24553094

Group type: COMPARATOR
Intervention: Nitrate maintenance (n=54)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Nitrate withdrawal followed by introduction of placebo (n=51)
Number of subjects: 105
Study: 23141856

Group type: EXPERIMENTAL
Intervention: High-intensification intravenous diuretic therapy
Number of subjects: 308

Group type: COMPARATOR
Intervention: Low-intensification intravenous diuretic therapy
Number of subjects: 308
Study: 20415693

Group type: EXPERIMENTAL
Intervention: Higher dose combination (sitagliptin 50 mg b.i.d. + metformin 1000 mg b.i.d.)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower dose combination (sitagliptin 50 mg b.i.d. + metformin 500 mg b.i.d.)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher dose metformin (metformin 1000 mg b.i.d.)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower dose metformin (metformin 500 mg b.i.d.)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sitagliptin monotherapy (sitagliptin 100 mg q.d.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo/metformin (switched to metformin monotherapy uptitrated to 1000 mg b.i.d.)
Number of subjects: 0
Study: 19173813

Group type: EXPERIMENTAL
Intervention: DNCE regimen
Number of subjects: 69

Group type: COMPARATOR
Intervention: DICE regimen
Number of subjects: 69
Study: 17086017

Group type: EXPERIMENTAL
Intervention: Hydrolyzed whey protein (20 g/d)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Unmodified whey protein (control treatment)
Number of subjects: 30
Study: 12675164

Group type: EXPERIMENTAL
Intervention: Routine home visiting by public health nurses (PHN)
Number of subjects: 733

Group type: COMPARATOR
Intervention: Screening telephone call
Number of subjects: 733
Study: 10486435

Group type: EXPERIMENTAL
Intervention: Film-coated tablet formulation of risedronate
Number of subjects: 25

Group type: COMPARATOR
Intervention: Gelatin capsule formulation of risedronate
Number of subjects: 25
Study: 1823735

Group type: EXPERIMENTAL
Intervention: Attenuated heart rate-limited treadmill stress testing
Number of subjects: 96

Group type: COMPARATOR
Intervention: Cinecoronary arteriography
Number of subjects: 96

Group type: COMPARATOR
Intervention: Multivessel coronary artery disease
Number of subjects: 96

Group type: COMPARATOR
Intervention: Left ventricular ejection fraction
Number of subjects: 96
Study: 7293955

Group type: EXPERIMENTAL
Intervention: Caffeinated coffee
Number of subjects: 0

Group type: COMPARATOR
Intervention: Decaffeinated coffee
Number of subjects: 0
Study: 6374946

Group type: EXPERIMENTAL
Intervention: Tube gastrostomy (Group G)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Nasogastric suction for 48 to 72 hours (Group NGS)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: No gastric decompression (Group ND)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (Group ND)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (Group NGS)
Number of subjects: 66
Study: 30351426

Group type: EXPERIMENTAL
Intervention: Personalized antibiotic strategies (COMPASS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SMART COMPASS
Number of subjects: 0
Study: 30672198

Group type: EXPERIMENTAL
Intervention: Walnut moxibustion
Number of subjects: 67

Group type: COMPARATOR
Intervention: Sodium hyaluronate eye drops
Number of subjects: 67
Study: 26846336

Group type: EXPERIMENTAL
Intervention: Spanish-language diabetes self-efficacy scale (DSES-S)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: English-language diabetes self-efficacy scale (DSES)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methods designed to enhance self-efficacy (treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 25231491

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 or 1 mg/kg)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 600
Study: 23257482

Group type: EXPERIMENTAL
Intervention: Custom‐made resin post + Self‐etch adhesive
Number of subjects: 40

Group type: COMPARATOR
Intervention: Glass FRC post + Self‐etch adhesive
Number of subjects: 40

Group type: COMPARATOR
Intervention: Custom‐made resin post + Etch and Rinse adhesive
Number of subjects: 40

Group type: COMPARATOR
Intervention: Glass FRC post + Etch and Rinse adhesive
Number of subjects: 40
Study: 20122421

Group type: EXPERIMENTAL
Intervention: Damon MX self-ligating brackets
Number of subjects: 70

Group type: COMPARATOR
Intervention: In-Ovation R self-ligating brackets
Number of subjects: 70
Study: 17631326

Group type: EXPERIMENTAL
Intervention: Radical radiotherapy
Number of subjects: 210

Group type: COMPARATOR
Intervention: Observation (control for group 1)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Intravesical therapy (control for group 2)
Number of subjects: 210
Study: 16239360

Group type: EXPERIMENTAL
Intervention: FTY720
Number of subjects: 0
Study: 12059939

Group type: EXPERIMENTAL
Intervention: Eugenol containing sealer (Kerr Pulp Canal Sealer)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Resin sealer (AH‐26)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide sealer (Sealapex)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (not obturated)
Number of subjects: 64
Study: 9952053

Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 570
Study: 7817931

Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 110

Group type: COMPARATOR
Intervention: Procainamide
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Sotalol (alternate therapy group)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Sotalol (overall efficacy)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Sotalol and Procainamide
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Sotalol (follow-up)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Procainamide (follow-up)
Number of subjects: 110
Study: 2266432

Group type: COMPARATOR
Intervention: Cross-covering senior resident (CC group)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Primary senior resident (PE group)
Number of subjects: 146
Study: 543911

Group type: EXPERIMENTAL
Intervention: mezlocillin (Baypen) at a daily dosage of 2 x 5 g or 3 x 5 g
Number of subjects: 44
Study: 31577876

Group type: EXPERIMENTAL
Intervention: Active community-wide screening for pulmonary tuberculosis using rapid nucleic acid amplification testing annually for 3 years.
Number of subjects: 83630

Group type: COMPARATOR
Intervention: Standard passive case detection alone (control group).
Number of subjects: 83630

Group type: EXPERIMENTAL
Intervention: Active community-wide screening for tuberculosis infection in children born in 2012.
Number of subjects: 83630
Study: 28397833

Group type: EXPERIMENTAL
Intervention: Short-term oral immunotherapy (OIT) with Cry j 1-galactomannan conjugate
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 26952142

Group type: EXPERIMENTAL
Intervention: Standardized extract of Prunus mume (150 mg)
Number of subjects: 45
Study: 24391490

Group type: EXPERIMENTAL
Intervention: Narrow model-free strategy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General model-based strategy
Number of subjects: 0
Study: 21940716

Group type: EXPERIMENTAL
Intervention: Paricalcitol (injection and capsules)
Number of subjects: 0
Study: 18198986

Group type: EXPERIMENTAL
Intervention: Fenofibrate treatment for 3 months
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (lean healthy women)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Hyperinsulinemia during the clamp
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Correlation analysis
Number of subjects: 11
Study: 17504997

Group type: EXPERIMENTAL
Intervention: PF-3512676 (CpG B-type oligodeoxynucleotide)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Saline (NaCl 0.9%)
Number of subjects: 23
Study: 15188947

Group type: EXPERIMENTAL
Intervention: 60 mg U/day of Ultrasome-CoQ10 for 3 months
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 32
Study: 11151290

Group type: EXPERIMENTAL
Intervention: Diet only treatment group
Number of subjects: 252

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 252
Study: 9343478

Group type: EXPERIMENTAL
Intervention: Amitriptylin
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Differentiated treatment based on clinical sleep disturbances (including amitriptylin, imipramine, diazepam, nootropic drugs)
Number of subjects: 367
Study: 8409069

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo (digoxin withdrawal)
Number of subjects: 88
Study: 3537823

Group type: EXPERIMENTAL
Intervention: Naftidrofuryl treatment
Number of subjects: 100
Study: 31464623

Group type: EXPERIMENTAL
Intervention: Voice short message service (SMS) on malaria prevention, once a week for twelve months
Number of subjects: 332

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Treatment effect at endline
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Baseline treatment effect
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Overall intervention effect
Number of subjects: 332
Study: 28249230

Group type: EXPERIMENTAL
Intervention: Parent panel intervention targeting discussions about future opportunities and responses to academic difficulty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 25588410

Group type: EXPERIMENTAL
Intervention: Midwife oral assessment and referral to private/public/health fund dental services pathway (Intervention Group 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Midwife oral assessment and referral to local free public dental services pathway (Intervention Group 2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral health promotional material only (Control Group)
Number of subjects: 0
Study: 22885010

Group type: EXPERIMENTAL
Intervention: Brief intervention (BI) for multi-substance use
Number of subjects: 853

Group type: EXPERIMENTAL
Intervention: Booster sessions
Number of subjects: 853

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 853
Study: 21672049

Group type: EXPERIMENTAL
Intervention: 20 ng/ml tacrolimus
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 18638594

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70